OR WAIT null SECS
June 16, 2022
The draft ICH Q9(R1) document details the importance of quality risk management principles.
The new draft guidance describes a standards recognition program for regenerative medicine therapies.
June 10, 2022
In the report, the agency presents the activities it accomplished in 2021 to protect and promote public health.
The agency’s Medicines Shortages Steering Group has adopted a list of critical COVID-19 vaccines and treatments so they may be monitored for potential shortages.
June 09, 2022
The Rockwell Experience Center will teach ARMI members how to increase delivery speeds by leveraging smart manufacturing in the scaling of regenerative medicine products.
June 07, 2022
Sanofi will grant Regeneron worldwide exclusive license rights to Libtayo, a treatment for non-small cell lung cancer.
June 03, 2022
Thermo Fisher Scientific and Qatar Genome Program will use custom genotyping arrays to accelerate genomic research in Qatar.
Cambrex’s acquisition of Q1 Scientific expands the company’s storage services in the European market.
June 02, 2022
Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.
June 01, 2022
Pfizer will provide all its current and future patent-protected medicines and vaccines available in the United States or EU on a not-for-profit basis to 45 lower-income countries.